Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Beginning in July 2026, CMS will launch a temporary Medicare GLP-1 Bridge program offering eligible Part D beneficiaries access to certain GLP-1 weight loss medications for obesity at an estimated $50 monthly copay
Tirzepatide is the more established of the two
Compounding may provide options for alternative dosing or injection styles preferred by some women
This may involve ongoing nutritional counseling, exercise programming and behavioral support to reinforce healthy habits
US$ 28.76
US$ 24.14
US$ 24.55
